Crinetics Pharmaceuticals, Inc. (CRNX) Income Statement 2017 - 2025

Crinetics Pharmaceuticals, Inc.

NasdaqGS:CRNX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 2.90 B

Share Price

USD 30.95

Avg Daily Volume

812,568

Change (1 day)

-0.51%

Change (1 year)

-41.23%

Change (YTD)

-39.47%

Crinetics Pharmaceuticals, Inc. Income Statement 2017 - 2025

This table shows the Income Statement for Crinetics Pharmaceuticals, Inc. going from 2017 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.